Selective targeted delivery of TNFalpha to tumor blood vessels. - Wikidata - wikimedia - TriplyDB

Selective targeted delivery of TNFalpha to tumor blood vessels.

Selective targeted delivery of TNFalpha to tumor blood vessels.

http://www.wikidata.org/entity/Q53855595

about

A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes The development of immunoconjugates for targeted cancer therapy Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site Novel ubiquitin-derived high affinity binding proteins with tumor targeting properties.Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma.Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma.Heptameric targeting ligands against EGFR and HER2 with high stability and avidity.A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels.Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies Use of the uteroglobin platform for the expression of a bivalent antibody against oncofetal fibronectin in Escherichia coli.Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.Development trends for generation of single-chain antibody fragments.TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.ED-B fibronectin as a target for antibody-based cancer treatments.Antibody-based antiangiogenic cancer therapy.Fibronectin as target for tumor therapy.Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site Gene therapy targeting to tumor endothelium.New approaches in metastatic melanoma: biological and molecular targeted therapies.The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer.Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins.Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells.Stromal Modulators of TGF-β in Cancer.Jekyll and Hyde: the role of the microenvironment on the progression of cancer.Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.Immunocytokines: a review of molecules in clinical development for cancer therapy.

P2860

Q24320137-83D68E7D-A67F-4506-A3D4-00BFD7DAB35C Q26991991-1DBAE9C2-7D04-461D-B3E8-65456BD920FE Q27021990-EF0C06D8-BD6D-4FB6-B4EF-394A8EE715FE Q27030560-7D93A50F-E0C3-498C-BB27-5EDE4A05D7AD Q28066935-FD956FB1-8D3D-4DF9-AC7E-717963E12B57 Q30317537-DD93D916-125A-456D-8B14-CBACB618FBDE Q33325343-72669701-4B6A-4BA8-AE78-B9734C2D8670 Q33531787-76E39E87-B004-4085-9376-B14F5736F6F4 Q33605532-083DB967-D919-43FF-B7B8-983390494282 Q33607479-98A9906D-840D-4B32-9F96-3AE572F997C5 Q34253705-14C690CC-6AF2-4107-B300-40B6E9B18954 Q34389242-4488D1B3-4F41-4AEE-B1DF-AC79D093CAC0 Q34746019-712E79C3-D8C1-4199-B82F-7A2D8D93AA2B Q34756337-AF1B03E8-6D3A-4580-8F98-863ED4F30753 Q35075470-27655C0B-ED97-4209-A15E-D3FC822CF500 Q35163167-6B2AA832-CAF2-4931-845F-7132BAAAF116 Q35216785-5CD79178-0416-4AAE-891E-342C7D25F12B Q35642213-C281BA0A-E413-470E-81E8-5B0DCCC4B489 Q35769069-9BBEEE8F-2FDB-42C0-BA45-4BA1D5123878 Q35974293-1FFCD80C-185A-4D35-AE60-77B65E13C832 Q36123270-93137EC8-0D87-44F5-8AAB-747DA059ED5B Q36158702-4626C748-43DC-461F-B11A-D884B81795B2 Q36318555-F3EB7C59-92C7-454D-B505-0EA8FDF651FA Q36354769-45350AEE-5F2A-4534-8C5C-A55B946EC0D6 Q36411863-169684CC-EE7B-4EFA-B6BF-8E420FC5CD0E Q36649681-5F94A3E7-7E4D-497F-91F3-9223F4EFAB23 Q36817127-B94E6745-4C96-4CA6-BA47-85914EFBE769 Q37185752-9DCA17DE-75D4-4130-8E76-ED1B5D2342CD Q37220415-9991E30C-37DE-4A1F-BECF-B97EF2604FB4 Q37236248-284A2CAE-B29B-4EF1-9034-82D7546D83E3 Q37294534-7922471C-1A83-4702-AC96-EBAC694D5693 Q37330712-4B9EEC75-7322-43FB-9FA6-B31065B75698 Q37446755-FDC841D6-AE1E-4A4C-ADA0-0A05EFB865BA Q37453905-A19930E8-E2E1-494D-8C39-29E0B986115D Q37485709-4C9A8C6F-C07F-49FD-95CF-CC25E4E692D8 Q37566991-1275A2E8-380D-4EE5-A4FA-FE1CBC6C3A94 Q37628179-E03D041C-B509-4A75-96A1-50E16DEADB63 Q37815128-562D787A-A2CA-4B89-BAF9-90B98D1530DF Q38066025-210C9983-6FF0-4A64-AEF2-FCB842724AFC Q38132742-2E931ADA-A14F-4462-B4D8-E4FF4E6D443C

P2860

Selective targeted delivery of TNFalpha to tumor blood vessels.

http://www.wikidata.org/entity/Q53855595

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Selective targeted delivery of TNFalpha to tumor blood vessels.

@en

Selective targeted delivery of TNFalpha to tumor blood vessels.

@nl

type

label

Selective targeted delivery of TNFalpha to tumor blood vessels.

@en

Selective targeted delivery of TNFalpha to tumor blood vessels.

@nl

prefLabel

Selective targeted delivery of TNFalpha to tumor blood vessels.

@en

Selective targeted delivery of TNFalpha to tumor blood vessels.

@nl

P1433

Q53855595-755F806D-EDDB-45AE-B54E-9B01849F66CF

P1476

Q53855595-4CECD0B6-076E-43FE-923A-840F3D9BBD01

P2093

Q53855595-0E6806AB-835A-4F7E-B584-E9727E6C2E3F

Q53855595-0E8D9856-7645-4D84-B238-BE1CC3467DA4

Q53855595-0EEAE310-3B55-4330-8A4C-6F92F8E6E2FD

Q53855595-2AFC317D-4FC1-4FDF-9DF4-B101C9A49B2C

Q53855595-2D49E0EE-8D92-4272-B445-63853B479223

Q53855595-4D759BF8-468C-4B3E-A5D3-C34AE6E3D5DC

Q53855595-52B2C198-9CD4-408D-9CF3-0AC28258FB2D

Q53855595-7D14ED81-26ED-40A3-A093-8A9E20680EE8

Q53855595-E5799626-7294-4ED0-904B-2351232381AC

Q53855595-EE5606B6-51F4-42D7-B780-5881B3171BF5

P304

Q53855595-1541B19D-1380-45C6-97DC-759BFC40860A

P31

Q53855595-B714A156-5CCD-4BF5-B52D-5312FD194768

P356

Q53855595-063EAC02-F43F-4434-94A3-219212022EC1

P407

Q53855595-066AE993-2CD4-41B3-950A-B4AA294842D5

P433

Q53855595-ADE6C13C-4143-4D97-8717-7CD241B83927

P478

Q53855595-24FDACA6-90F2-4A71-A0AA-E90D0021531D

P50

Q53855595-E9F4D553-6220-4033-99C0-B0396D4D6077

P577

Q53855595-52F4CD06-2A47-4029-864D-C8E886C939AE

P5875

Q53855595-6AEA986E-CBB9-4A29-B100-5025F3FC0BF2

P698

Q53855595-E66F06D3-F94F-4721-B7BB-3D95F3EE80C0

P356

BLOOD-2003-04-1039

P1433

P1476

Selective targeted delivery of TNFalpha to tumor blood vessels

@en

P2093

Alexander Berndt

http://www.w3.org/2001/XMLSchema#string

Annalisa Siri

http://www.w3.org/2001/XMLSchema#string

Attila Biro

http://www.w3.org/2001/XMLSchema#string

Barbara Carnemolla

http://www.w3.org/2001/XMLSchema#string

Dario Neri

http://www.w3.org/2001/XMLSchema#string

Enrica Balza

http://www.w3.org/2001/XMLSchema#string

Francesca Sassi

http://www.w3.org/2001/XMLSchema#string

Hartwig Kosmehl

http://www.w3.org/2001/XMLSchema#string

Jessica Grassi

http://www.w3.org/2001/XMLSchema#string

Laura Borsi

http://www.w3.org/2001/XMLSchema#string

P304

4384-4392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2003-04-1039

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10601036

http://www.w3.org/2001/XMLSchema#string

P698

12933583

http://www.w3.org/2001/XMLSchema#string